Source: European Journal of Pharmacology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-JUNIOR, Edgar Borges de et al. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells. European Journal of Pharmacology, v. 567, n. 1-2, p. 43-49, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2007.04.018. Acesso em: 03 out. 2024.APA
Oliveira-Junior, E. B. de, Thomazzi, S. M., Rehder, J., Antunes, E., & Condino-Neto, A. (2007). Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells. European Journal of Pharmacology, 567( 1-2), 43-49. doi:10.1016/j.ejphar.2007.04.018NLM
Oliveira-Junior EB de, Thomazzi SM, Rehder J, Antunes E, Condino-Neto A. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells [Internet]. European Journal of Pharmacology. 2007 ; 567( 1-2): 43-49.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2007.04.018Vancouver
Oliveira-Junior EB de, Thomazzi SM, Rehder J, Antunes E, Condino-Neto A. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells [Internet]. European Journal of Pharmacology. 2007 ; 567( 1-2): 43-49.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.ejphar.2007.04.018
